US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Axsome Therapeutics

156.35

-7.9150-4.82%

Post-market: 156.350.00000.00%19:21 EDT

Volume:680.80K

Turnover:107.84M

Market Cap:8.00B

PE:-42.49

High:163.89

Open:163.89

Low:155.56

Close:164.27

52wk High:191.50

52wk Low:86.99

Shares:51.15M

Float Shares:41.87M

Volume Ratio:1.05

T/O Rate:1.63%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-3.6800

EPS(LYR):-3.6821

ROE:-252.11%

ROA:-16.81%

PB:90.58

PE(LYR):-42.46

Loading ...

Overview Company News Filings

Axsome Therapeutics Is Maintained at Buy by Guggenheim

Axsome Therapeutics price target raised to $245 from $220 at Guggenheim

Axsome Still Offers 'Compelling' Core Story, RBC Says

MT Newswires Live

RBC Capital Remains a Buy on Axsome Therapeutics (AXSM)

Should Axsome’s New Solriamfetol Phase 3 and AXS-05 Priority Review Prompt Action From AXSM Investors?

Simply Wall St.

Should Axsome’s Revenue Jump and SUNOSI IP Win Require Action From Axsome Therapeutics (AXSM) Investors?

Simply Wall St.

Axsome Therapeutics Director Mark Coleman Disposes of Common Shares

Axsome Explores Solriamfetol In Phase 3 CLARITY Trial For MDD Subset

Simply Wall St.

Axsome Therapeutics to Participate in Upcoming Investor Conferences

RBC Raises Price Target on Axsome Therapeutics to $222 From $219, Keeps Outperform Rating

MT Newswires Live

Axsome Therapeutics Initiated at Outperform by Wolfe Research

Axsome announces first patient dosed in CLARITY Phase 3 trial of solriamfetol

BRIEF-Axsome Therapeutics Initiates Clarity Phase 3 Trial Of Solriamfetol In Adults With Major Depressive Disorder

Axsome doses first patient in CLARITY Phase 3 solriamfetol trial for MDD with excessive daytime sleepiness symptoms

Axsome Therapeutics Initiates Clarity Phase 3 Trial of Solriamfetol in Adults With Major Depressive Disorder With Excessive Daytime Sleepiness Symptoms

THOMSON REUTERS

RBC Capital Sticks to Their Buy Rating for Axsome Therapeutics (AXSM)

Axsome Therapeutics price target raised to $202 from $193 at Wells Fargo

U.S. RESEARCH ROUNDUP-Dollar General, Keysight Technologies, Teledyne Technologies

Axsome Therapeutics Signals Strong Growth in Earnings Call

Axsome Therapeutics price target raised to $215 from $195 at TD Cowen

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/AXSM/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"AXSM","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AXSM\",,,,,undefined,":{"symbol":"AXSM","market":"US","secType":"STK","nameCN":"Axsome Therapeutics","latestPrice":156.35,"timestamp":1774641600000,"preClose":164.265,"halted":0,"volume":680802,"hourTrading":{"tag":"盘后","latestPrice":156.35,"preClose":156.35,"latestTime":"19:21 EDT","volume":20496,"amount":3204582.75,"timestamp":1774653703003,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.04818433628587948,"floatShares":41872836,"shares":51153289,"eps":-3.68,"marketStatus":"Market Closed","change":-7.915,"latestTime":"03-27 16:00:00 EDT","open":163.89,"high":163.89,"low":155.5601,"amount":107836796.96142001,"amplitude":0.05071,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.68,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1774857600000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1447909200000,"exchange":"NASDAQ","adjPreClose":164.265,"preHourTrading":{"tag":"盘前","latestPrice":163.71,"preClose":164.265,"latestTime":"09:19 EDT","volume":50,"amount":8205.2605,"timestamp":1774617575906,"change":-0.555,"changeRate":-0.003379,"amplitude":0.012115},"postHourTrading":{"tag":"盘后","latestPrice":156.35,"preClose":156.35,"latestTime":"19:21 EDT","volume":20496,"amount":3204582.75,"timestamp":1774653703003,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.047255,"impliedVol":0.5993,"impliedVolPercentile":0.9641},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AXSM\",,,,,undefined,":{"symbol":"AXSM","floatShares":41872836,"roa":"-16.81%","roe":"-252.11%","lyrEps":-3.682098,"volumeRatio":1.047255,"shares":51153289,"dividePrice":0,"high":163.89,"amplitude":0.05071,"preClose":164.265,"low":155.5601,"week52Low":86.99,"pbRate":"90.58","psRate":"12.53","week52High":191.5,"institutionHeld":0,"latestPrice":156.35,"eps":-3.68,"divideRate":0,"volume":680802,"delay":0,"ttmEps":-3.68,"open":163.89,"prevYearClose":182.64,"prevWeekClose":156.92,"prevMonthClose":163.89,"prevQuarterClose":182.64,"fiveDayClose":156.92,"twentyDayClose":163.89,"sixtyDayClose":148.79},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/AXSM\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-02-23","symbol":"AXSM","fiscalQuarterEnding":"2025/12","expectedEps":-0.7,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1771822800000,"reportTimeType":"pre","actualEps":-0.71},{"date":"2026-01-12","symbol":"AXSM","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1768208400000,"name":null,"time":"Pre-Market","dateTimestamp":1768194000000,"actualEps":null},{"market":"US","date":"2025-11-03","symbol":"AXSM","fiscalQuarterEnding":"2025/09","expectedEps":-0.82,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1762146000000,"reportTimeType":"pre","actualEps":-0.94},{"market":"US","date":"2025-08-04","symbol":"AXSM","fiscalQuarterEnding":"2025/06","expectedEps":1,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1754280000000,"reportTimeType":"pre","actualEps":-0.92},{"market":"US","date":"2025-05-05","symbol":"AXSM","fiscalQuarterEnding":"2025/03","expectedEps":-1.26,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1746417600000,"reportTimeType":"pre","actualEps":-0.8}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"AXSM\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"AXSM\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.35,"buy":0.6,"hold":0.05,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6,"analysts":20,"updateTime":1767931200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/AXSM\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"AXSM","date":"2026-03-27","current":-42.486413,"percent":0.004874,"low":-50.562909,"twenty":-21.397007,"median":-16.733475,"eighty":-12.082137,"high":-6.009438,"avg":-17.914128,"sd":7.68058,"marketCap":8402695017},"quantilePoints":[{"date":"2021-04-01","current":-20.901753,"twenty":-28.78446,"median":-13.760518,"eighty":-3.76982,"marketCap":2150802910},{"date":"2021-04-09","current":-19.262328,"twenty":-28.770928,"median":-13.971843,"eighty":-3.76982,"marketCap":1982105151},{"date":"2021-04-16","current":-19.425907,"twenty":-28.764865,"median":-14.131173,"eighty":-3.800991,"marketCap":1998937521},{"date":"2021-04-23","current":-19.307504,"twenty":-28.757285,"median":-14.335102,"eighty":-3.816578,"marketCap":1986753718},{"date":"2021-04-30","current":-22.070934,"twenty":-28.740179,"median":-14.508939,"eighty":-3.818526,"marketCap":2271112305},{"date":"2021-05-07","current":-20.793258,"twenty":-28.736281,"median":-14.681183,"eighty":-3.818526,"marketCap":2139638718},{"date":"2021-05-14","current":-22.019873,"twenty":-28.701655,"median":-14.801134,"eighty":-3.818526,"marketCap":2194862183},{"date":"2021-05-21","current":-20.870256,"twenty":-28.655296,"median":-14.864222,"eighty":-3.826319,"marketCap":2080272494},{"date":"2021-05-28","current":-22.883028,"twenty":-28.636775,"median":-14.92072,"eighty":-3.83606,"marketCap":2280898376},{"date":"2021-06-04","current":-23.112951,"twenty":-28.62768,"median":-15.069857,"eighty":-3.849697,"marketCap":2303816314},{"date":"2021-06-11","current":-25.023953,"twenty":-28.565893,"median":-15.2723,"eighty":-3.85749,"marketCap":2494298192},{"date":"2021-06-18","current":-25.3858,"twenty":-28.525855,"median":-15.395896,"eighty":-3.892558,"marketCap":2530365766},{"date":"2021-06-25","current":-27.70388,"twenty":-28.520054,"median":-15.583979,"eighty":-3.962694,"marketCap":2761423665},{"date":"2021-07-02","current":-24.89203,"twenty":-28.501106,"median":-15.829585,"eighty":-4.001321,"marketCap":2481148555},{"date":"2021-07-09","current":-24.620645,"twenty":-28.488077,"median":-16.072993,"eighty":-4.020803,"marketCap":2454097874},{"date":"2021-07-16","current":-20.436794,"twenty":-28.467162,"median":-16.281692,"eighty":-4.296588,"marketCap":2037066545},{"date":"2021-07-23","current":-20.233255,"twenty":-28.441204,"median":-16.586109,"eighty":-4.680907,"marketCap":2016778535},{"date":"2021-07-30","current":-18.314715,"twenty":-28.433613,"median":-16.793478,"eighty":-4.685848,"marketCap":1825545250},{"date":"2021-08-06","current":-19.283408,"twenty":-28.418818,"median":-17.12943,"eighty":-4.706221,"marketCap":1922101152},{"date":"2021-08-13","current":-7.580584,"twenty":-28.417086,"median":-16.637241,"eighty":-4.716408,"marketCap":861409331},{"date":"2021-08-20","current":-7.149492,"twenty":-28.417086,"median":-16.132105,"eighty":-4.716408,"marketCap":812422798},{"date":"2021-08-27","current":-7.958618,"twenty":-28.417086,"median":-15.583979,"eighty":-4.716408,"marketCap":904366752},{"date":"2021-09-03","current":-8.850647,"twenty":-28.417086,"median":-15.2723,"eighty":-4.716408,"marketCap":1005731192},{"date":"2021-09-10","current":-9.082773,"twenty":-28.417086,"median":-14.928377,"eighty":-4.716408,"marketCap":1032108555},{"date":"2021-09-17","current":-9.855422,"twenty":-28.417086,"median":-14.839801,"eighty":-4.716408,"marketCap":1119907494},{"date":"2021-09-24","current":-11.075744,"twenty":-28.417086,"median":-14.51997,"eighty":-4.716408,"marketCap":1258577063},{"date":"2021-10-01","current":-11.36756,"twenty":-28.417086,"median":-14.177504,"eighty":-4.716408,"marketCap":1291737177},{"date":"2021-10-08","current":-10.677813,"twenty":-28.417086,"median":-13.899514,"eighty":-4.716408,"marketCap":1213358725},{"date":"2021-10-15","current":-13.297524,"twenty":-28.417086,"median":-13.602473,"eighty":-4.716408,"marketCap":1511046114},{"date":"2021-10-22","current":-13.297524,"twenty":-28.417086,"median":-13.469961,"eighty":-4.716408,"marketCap":1511046114},{"date":"2021-10-29","current":-12.76695,"twenty":-28.417086,"median":-13.144984,"eighty":-4.716408,"marketCap":1450754998},{"date":"2021-11-05","current":-13.330685,"twenty":-28.417086,"median":-13.115139,"eighty":-4.716408,"marketCap":1514814309},{"date":"2021-11-12","current":-11.782465,"twenty":-28.417086,"median":-12.97288,"eighty":-4.716408,"marketCap":1479777437},{"date":"2021-11-19","current":-10.744071,"twenty":-28.417086,"median":-12.694889,"eighty":-4.716408,"marketCap":1349364041},{"date":"2021-11-26","current":-11.080198,"twenty":-28.417086,"median":-12.602226,"eighty":-4.716408,"marketCap":1391578782},{"date":"2021-12-03","current":-9.675666,"twenty":-28.417086,"median":-12.509562,"eighty":-4.716408,"marketCap":1215181471},{"date":"2021-12-10","current":-9.94877,"twenty":-28.417086,"median":-12.327465,"eighty":-4.716408,"marketCap":1249480948},{"date":"2021-12-17","current":-10.594014,"twenty":-28.417086,"median":-12.327465,"eighty":-4.716408,"marketCap":1330518174},{"date":"2021-12-23","current":-11.539372,"twenty":-28.417086,"median":-12.235636,"eighty":-4.716408,"marketCap":1449247133},{"date":"2021-12-31","current":-11.338296,"twenty":-28.417086,"median":-11.768255,"eighty":-4.716408,"marketCap":1423993672},{"date":"2022-01-07","current":-9.876742,"twenty":-28.415355,"median":-11.543874,"eighty":-4.726594,"marketCap":1240434933},{"date":"2022-01-14","current":-8.583252,"twenty":-28.415355,"median":-11.543874,"eighty":-4.726594,"marketCap":1077983563},{"date":"2022-01-21","current":-7.114196,"twenty":-28.415355,"median":-11.543874,"eighty":-4.726594,"marketCap":893482530},{"date":"2022-01-28","current":-7.898993,"twenty":-28.415355,"median":-11.543874,"eighty":-4.726594,"marketCap":992046412},{"date":"2022-02-04","current":-8.616265,"twenty":-28.415355,"median":-11.543874,"eighty":-4.726594,"marketCap":1082129654},{"date":"2022-02-11","current":-9.621646,"twenty":-28.415355,"median":-11.543874,"eighty":-4.726594,"marketCap":1208396959},{"date":"2022-02-18","current":-8.874363,"twenty":-28.415355,"median":-11.543874,"eighty":-4.726594,"marketCap":1114544544},{"date":"2022-02-25","current":-8.460206,"twenty":-28.415355,"median":-11.543874,"eighty":-4.726594,"marketCap":1062529953},{"date":"2022-03-04","current":-8.825214,"twenty":-28.415355,"median":-11.543874,"eighty":-4.726594,"marketCap":1150834298},{"date":"2022-03-11","current":-9.674984,"twenty":-28.415355,"median":-11.543874,"eighty":-4.726594,"marketCap":1261646828},{"date":"2022-03-18","current":-9.916932,"twenty":-28.415355,"median":-11.543874,"eighty":-4.726594,"marketCap":1293197618},{"date":"2022-03-25","current":-10.433285,"twenty":-28.415355,"median":-11.543874,"eighty":-4.726594,"marketCap":1360531621},{"date":"2022-04-01","current":-12.95604,"twenty":-28.415355,"median":-11.795362,"eighty":-4.726594,"marketCap":1689506320},{"date":"2022-04-08","current":-12.00595,"twenty":-28.415355,"median":-12.224063,"eighty":-4.726594,"marketCap":1565611755},{"date":"2022-04-14","current":-10.875874,"twenty":-28.415355,"median":-12.224063,"eighty":-4.726594,"marketCap":1418246480},{"date":"2022-04-22","current":-11.667797,"twenty":-28.415355,"median":-12.28155,"eighty":-4.726594,"marketCap":1521515699},{"date":"2022-04-29","current":-9.47449,"twenty":-28.415355,"median":-12.28155,"eighty":-4.726594,"marketCap":1235501878},{"date":"2022-05-06","current":-8.242936,"twenty":-28.415355,"median":-12.28155,"eighty":-4.726594,"marketCap":1160402061},{"date":"2022-05-13","current":-7.712204,"twenty":-28.415355,"median":-12.28155,"eighty":-4.726594,"marketCap":1085688045},{"date":"2022-05-20","current":-8.74879,"twenty":-28.415355,"median":-12.28155,"eighty":-4.726594,"marketCap":1231613857},{"date":"2022-05-27","current":-7.314154,"twenty":-28.415355,"median":-12.28155,"eighty":-4.726594,"marketCap":1029652533},{"date":"2022-06-03","current":-7.057081,"twenty":-28.415355,"median":-12.28155,"eighty":-4.726594,"marketCap":993462931},{"date":"2022-06-10","current":-6.730902,"twenty":-28.415355,"median":-12.28155,"eighty":-4.726594,"marketCap":947544942},{"date":"2022-06-17","current":-6.272039,"twenty":-28.415355,"median":-12.28155,"eighty":-4.726594,"marketCap":882948449},{"date":"2022-06-24","current":-6.761308,"twenty":-28.417086,"median":-12.327465,"eighty":-4.716408,"marketCap":951825433},{"date":"2022-07-01","current":-11.233834,"twenty":-28.417086,"median":-12.327465,"eighty":-4.716408,"marketCap":1581446672},{"date":"2022-07-08","current":-12.604892,"twenty":-28.417086,"median":-12.531507,"eighty":-4.716408,"marketCap":1774457880},{"date":"2022-07-15","current":-12.076924,"twenty":-28.417086,"median":-12.531507,"eighty":-4.716408,"marketCap":1700132999},{"date":"2022-07-22","current":-11.142614,"twenty":-28.417086,"median":-12.531507,"eighty":-4.716408,"marketCap":1568605200},{"date":"2022-07-29","current":-10.667166,"twenty":-28.417086,"median":-12.531507,"eighty":-4.716408,"marketCap":1501673894},{"date":"2022-08-05","current":-12.007818,"twenty":-28.417086,"median":-12.531507,"eighty":-4.716408,"marketCap":1690404612},{"date":"2022-08-12","current":-12.438313,"twenty":-28.417086,"median":-12.604892,"eighty":-4.716408,"marketCap":1864871817},{"date":"2022-08-19","current":-16.008246,"twenty":-28.417086,"median":-12.734015,"eighty":-4.716408,"marketCap":2400110584},{"date":"2022-08-26","current":-19.19834,"twenty":-28.417086,"median":-13.012341,"eighty":-4.716408,"marketCap":2878400274},{"date":"2022-09-02","current":-18.014352,"twenty":-28.417086,"median":-13.144984,"eighty":-4.716408,"marketCap":2700885345},{"date":"2022-09-09","current":-17.751244,"twenty":-28.417086,"median":-13.297524,"eighty":-4.716408,"marketCap":2661437584},{"date":"2022-09-16","current":-16.93046,"twenty":-28.417086,"median":-13.546231,"eighty":-4.716408,"marketCap":2538377718},{"date":"2022-09-23","current":-14.373731,"twenty":-28.417086,"median":-13.785155,"eighty":-4.716408,"marketCap":2155048380},{"date":"2022-09-30","current":-12.760762,"twenty":-28.417086,"median":-13.785155,"eighty":-4.716408,"marketCap":1913216449},{"date":"2022-10-07","current":-13.103947,"twenty":-28.417086,"median":-13.794007,"eighty":-4.716408,"marketCap":1964670051},{"date":"2022-10-14","current":-13.7274,"twenty":-28.417086,"median":-13.794007,"eighty":-4.716408,"marketCap":2058144096},{"date":"2022-10-21","current":-11.862761,"twenty":-28.417086,"median":-13.794007,"eighty":-4.716408,"marketCap":1778579522},{"date":"2022-10-28","current":-12.102991,"twenty":-28.417086,"median":-13.794007,"eighty":-4.716408,"marketCap":1814597044},{"date":"2022-11-04","current":-16.327026,"twenty":-28.417086,"median":-13.971843,"eighty":-4.716408,"marketCap":2447905134},{"date":"2022-11-11","current":-16.029117,"twenty":-28.417086,"median":-14.373731,"eighty":-4.767341,"marketCap":2562577819},{"date":"2022-11-18","current":-15.257677,"twenty":-28.417086,"median":-14.497908,"eighty":-4.79395,"marketCap":2439247519},{"date":"2022-11-25","current":-15.434239,"twenty":-28.417086,"median":-14.724173,"eighty":-4.898255,"marketCap":2467474524},{"date":"2022-12-02","current":-20.888648,"twenty":-28.417086,"median":-14.896404,"eighty":-4.898255,"marketCap":3339471857},{"date":"2022-12-09","current":-20.334515,"twenty":-28.417086,"median":-14.934267,"eighty":-4.898255,"marketCap":3250882487},{"date":"2022-12-16","current":-21.296099,"twenty":-28.417086,"median":-15.271259,"eighty":-4.898255,"marketCap":3404611100},{"date":"2022-12-23","current":-20.043867,"twenty":-28.417086,"median":-15.412018,"eighty":-4.898255,"marketCap":3204416493},{"date":"2022-12-30","current":-20.951124,"twenty":-28.417086,"median":-15.545609,"eighty":-4.898255,"marketCap":3349459875},{"date":"2023-01-06","current":-18.46839,"twenty":-28.417086,"median":-15.702202,"eighty":-6.20404,"marketCap":2952544754},{"date":"2023-01-13","current":-18.280963,"twenty":-28.417086,"median":-16.029117,"eighty":-6.567519,"marketCap":2922580702},{"date":"2023-01-20","current":-19.23983,"twenty":-28.417086,"median":-16.281692,"eighty":-6.731359,"marketCap":3075875054},{"date":"2023-01-27","current":-19.087715,"twenty":-28.417086,"median":-16.637241,"eighty":-6.946485,"marketCap":3051556403},{"date":"2023-02-03","current":-18.66125,"twenty":-28.417086,"median":-17.062014,"eighty":-7.089998,"marketCap":2983377329},{"date":"2023-02-10","current":-17.055894,"twenty":-28.417086,"median":-17.13163,"eighty":-7.187,"marketCap":2726728711},{"date":"2023-02-17","current":-18.096252,"twenty":-28.417086,"median":-17.237888,"eighty":-7.373862,"marketCap":2893050912},{"date":"2023-02-24","current":-16.583251,"twenty":-28.417086,"median":-17.237888,"eighty":-7.712635,"marketCap":2651167190},{"date":"2023-03-03","current":-15.180365,"twenty":-28.417086,"median":-17.237888,"eighty":-7.893661,"marketCap":2840757185},{"date":"2023-03-10","current":-13.578148,"twenty":-28.417086,"median":-17.237888,"eighty":-8.043265,"marketCap":2540928493},{"date":"2023-03-17","current":-14.589708,"twenty":-28.417086,"median":-17.237888,"eighty":-8.219199,"marketCap":2730225272},{"date":"2023-03-24","current":-14.408325,"twenty":-28.417086,"median":-17.237888,"eighty":-8.347465,"marketCap":2696282401},{"date":"2023-03-31","current":-14.343213,"twenty":-28.415355,"median":-17.237888,"eighty":-8.438189,"marketCap":2684097781},{"date":"2023-04-06","current":-13.582799,"twenty":-28.415355,"median":-17.237888,"eighty":-8.515067,"marketCap":2541798823},{"date":"2023-04-14","current":-15.126881,"twenty":-28.417086,"median":-17.237888,"eighty":-8.590342,"marketCap":2830748390},{"date":"2023-04-21","current":-16.577945,"twenty":-28.417086,"median":-17.237888,"eighty":-8.633548,"marketCap":3102291356},{"date":"2023-04-28","current":-16.560131,"twenty":-28.417086,"median":-17.237888,"eighty":-8.782049,"marketCap":3098957798},{"date":"2023-05-05","current":-16.557804,"twenty":-28.417086,"median":-17.237888,"eighty":-8.912326,"marketCap":3098522307},{"date":"2023-05-12","current":-21.39324,"twenty":-28.417086,"median":-17.328154,"eighty":-9.013947,"marketCap":3395527537},{"date":"2023-05-19","current":-21.103076,"twenty":-28.417086,"median":-17.513874,"eighty":-9.093997,"marketCap":3349472883},{"date":"2023-05-26","current":-18.692708,"twenty":-28.417086,"median":-17.629041,"eighty":-9.135139,"marketCap":2966900073},{"date":"2023-06-02","current":-19.97476,"twenty":-28.417086,"median":-17.77844,"eighty":-9.187407,"marketCap":3170386977},{"date":"2023-06-09","current":-20.655593,"twenty":-28.417086,"median":-17.924982,"eighty":-9.24781,"marketCap":3278448546},{"date":"2023-06-16","current":-23.233424,"twenty":-28.417086,"median":-18.014352,"eighty":-9.337052,"marketCap":3687601016},{"date":"2023-06-23","current":-24.803733,"twenty":-28.418818,"median":-18.297839,"eighty":-9.445345,"marketCap":3936839794},{"date":"2023-06-30","current":-20.073591,"twenty":-28.420549,"median":-18.46839,"eighty":-9.469338,"marketCap":3186073334},{"date":"2023-07-07","current":-20.290469,"twenty":-28.420549,"median":-18.576208,"eighty":-9.560131,"marketCap":3220496172},{"date":"2023-07-14","current":-20.040647,"twenty":-28.420549,"median":-18.698313,"eighty":-9.653222,"marketCap":3180844549},{"date":"2023-07-21","current":-20.433224,"twenty":-28.420549,"median":-18.862469,"eighty":-9.751865,"marketCap":3243154243},{"date":"2023-07-28","current":-21.245831,"twenty":-28.420549,"median":-18.946466,"eighty":-9.838866,"marketCap":3372130954},{"date":"2023-08-04","current":-20.666574,"twenty":-28.420549,"median":-19.022523,"eighty":-9.919098,"marketCap":3280191474},{"date":"2023-08-11","current":-18.037146,"twenty":-28.420549,"median":-19.022523,"eighty":-9.959731,"marketCap":3326963385},{"date":"2023-08-18","current":-17.717339,"twenty":-28.420549,"median":-19.022523,"eighty":-10.057126,"marketCap":3267974672},{"date":"2023-08-25","current":-19.290792,"twenty":-28.420549,"median":-19.061023,"eighty":-10.126968,"marketCap":3558199138},{"date":"2023-09-01","current":-20.672361,"twenty":-28.420549,"median":-19.094946,"eighty":-10.228966,"marketCap":3813030376},{"date":"2023-09-08","current":-20.830985,"twenty":-28.420549,"median":-19.19834,"eighty":-10.246301,"marketCap":3842288777},{"date":"2023-09-15","current":-19.495469,"twenty":-28.420549,"median":-19.262328,"eighty":-10.349328,"marketCap":3595951914},{"date":"2023-09-22","current":-19.119375,"twenty":-28.420549,"median":-19.262328,"eighty":-10.378868,"marketCap":3526581188},{"date":"2023-09-29","current":-18.692112,"twenty":-28.420549,"median":-19.262328,"eighty":-10.440043,"marketCap":3447772268},{"date":"2023-10-06","current":-17.23379,"twenty":-28.420549,"median":-19.262328,"eighty":-10.525456,"marketCap":3178783739},{"date":"2023-10-13","current":-17.016321,"twenty":-28.420549,"median":-19.262328,"eighty":-10.598456,"marketCap":3138671414},{"date":"2023-10-20","current":-16.438109,"twenty":-28.420549,"median":-19.262328,"eighty":-10.646711,"marketCap":3032019822},{"date":"2023-10-27","current":-16.386939,"twenty":-28.429835,"median":-19.282946,"eighty":-10.674305,"marketCap":3022581628},{"date":"2023-11-03","current":-16.476485,"twenty":-28.429835,"median":-19.282946,"eighty":-10.808289,"marketCap":3039098468},{"date":"2023-11-10","current":-14.081381,"twenty":-28.429835,"median":-19.282946,"eighty":-10.929836,"marketCap":2842011992},{"date":"2023-11-17","current":-13.999321,"twenty":-28.429835,"median":-19.282946,"eighty":-11.058288,"marketCap":2825450151},{"date":"2023-11-24","current":-14.665174,"twenty":-28.429835,"median":-19.282946,"eighty":-11.129652,"marketCap":2959837664},{"date":"2023-12-01","current":-15.814005,"twenty":-28.429835,"median":-19.282946,"eighty":-11.282106,"marketCap":3191703445},{"date":"2023-12-08","current":-16.46579,"twenty":-28.426058,"median":-19.282946,"eighty":-11.336853,"marketCap":3323251785},{"date":"2023-12-15","current":-17.178534,"twenty":-28.426058,"median":-19.282946,"eighty":-11.380162,"marketCap":3467103208},{"date":"2023-12-22","current":-16.993315,"twenty":-28.426058,"median":-19.282946,"eighty":-11.419937,"marketCap":3429720766},{"date":"2023-12-29","current":-18.667325,"twenty":-28.429835,"median":-19.282946,"eighty":-11.503011,"marketCap":3767582332},{"date":"2024-01-05","current":-19.222984,"twenty":-28.433613,"median":-19.282946,"eighty":-11.566713,"marketCap":3879729658},{"date":"2024-01-12","current":-20.245209,"twenty":-28.433613,"median":-19.306357,"eighty":-11.683287,"marketCap":4086042883},{"date":"2024-01-19","current":-19.811466,"twenty":-28.43739,"median":-19.389342,"eighty":-11.809472,"marketCap":3998501721},{"date":"2024-01-26","current":-21.239299,"twenty":-28.433613,"median":-19.465893,"eighty":-11.861401,"marketCap":4286677762},{"date":"2024-02-02","current":-21.909841,"twenty":-28.433613,"median":-19.601888,"eighty":-11.983144,"marketCap":4422011667},{"date":"2024-02-09","current":-22.432676,"twenty":-28.433613,"median":-19.675324,"eighty":-12.075057,"marketCap":4527534256},{"date":"2024-02-16","current":-21.912185,"twenty":-28.433613,"median":-19.76274,"eighty":-12.186969,"marketCap":4422484862},{"date":"2024-02-23","current":-15.927086,"twenty":-28.433613,"median":-19.76274,"eighty":-12.293238,"marketCap":3810364180},{"date":"2024-03-01","current":-16.115026,"twenty":-28.429835,"median":-19.739727,"eighty":-12.506682,"marketCap":3855326637},{"date":"2024-03-08","current":-14.265501,"twenty":-28.429835,"median":-19.739727,"eighty":-12.677006,"marketCap":3412849975},{"date":"2024-03-15","current":-13.810051,"twenty":-28.429835,"median":-19.739727,"eighty":-12.869437,"marketCap":3303888912},{"date":"2024-03-22","current":-16.012055,"twenty":-28.429835,"median":-19.739727,"eighty":-12.938558,"marketCap":3830691962},{"date":"2024-03-28","current":-15.677398,"twenty":-28.429835,"median":-19.739727,"eighty":-12.938558,"marketCap":3750629268},{"date":"2024-04-05","current":-14.291244,"twenty":-28.433613,"median":-19.76274,"eighty":-12.929817,"marketCap":3419008643},{"date":"2024-04-12","current":-14.204114,"twenty":-28.433613,"median":-19.76274,"eighty":-12.929817,"marketCap":3398163918},{"date":"2024-04-19","current":-13.014002,"twenty":-28.433613,"median":-19.76274,"eighty":-12.929817,"marketCap":3113443925},{"date":"2024-04-26","current":-14.16253,"twenty":-28.429835,"median":-19.739727,"eighty":-12.938558,"marketCap":3388215300},{"date":"2024-05-03","current":-14.728134,"twenty":-28.429835,"median":-19.739727,"eighty":-12.938558,"marketCap":3523529410},{"date":"2024-05-10","current":-11.807571,"twenty":-28.429835,"median":-19.701371,"eighty":-12.750063,"marketCap":3499492533},{"date":"2024-05-17","current":-12.395706,"twenty":-28.429835,"median":-19.649302,"eighty":-12.578012,"marketCap":3673802218},{"date":"2024-05-24","current":-11.887699,"twenty":-28.429835,"median":-19.525695,"eighty":-12.436014,"marketCap":3523240446},{"date":"2024-05-31","current":-11.892506,"twenty":-28.429835,"median":-19.442778,"eighty":-12.367228,"marketCap":3524665321},{"date":"2024-06-07","current":-11.980646,"twenty":-28.429835,"median":-19.343656,"eighty":-12.253794,"marketCap":3550788026},{"date":"2024-06-14","current":-11.620073,"twenty":-28.433613,"median":-19.298009,"eighty":-12.177866,"marketCap":3443922415},{"date":"2024-06-21","current":-12.047953,"twenty":-28.43739,"median":-19.272637,"eighty":-12.168336,"marketCap":3570736273},{"date":"2024-06-28","current":-12.834804,"twenty":-28.441192,"median":-19.23983,"eighty":-12.143826,"marketCap":3803940784},{"date":"2024-07-05","current":-12.854035,"twenty":-28.441192,"median":-19.19834,"eighty":-12.143826,"marketCap":3809640283},{"date":"2024-07-12","current":-13.549541,"twenty":-28.441192,"median":-19.087715,"eighty":-12.143826,"marketCap":4015772172},{"date":"2024-07-15","current":-13.273902,"twenty":-28.441192,"median":-19.07844,"eighty":-12.143826,"marketCap":3934079350},{"date":"2024-08-02","current":-13.783512,"twenty":-28.490495,"median":-18.952635,"eighty":-12.102991,"marketCap":4085116080},{"date":"2024-08-09","current":-13.223111,"twenty":-28.490495,"median":-18.859161,"eighty":-12.102991,"marketCap":4080017425},{"date":"2024-08-16","current":-13.318007,"twenty":-28.490495,"median":-18.73003,"eighty":-12.102991,"marketCap":4109297550},{"date":"2024-08-23","current":-13.551356,"twenty":-28.490495,"median":-18.673323,"eighty":-12.102991,"marketCap":4181297857},{"date":"2024-08-30","current":-13.862488,"twenty":-28.490495,"median":-18.56764,"eighty":-12.102991,"marketCap":4277298267},{"date":"2024-09-06","current":-14.57498,"twenty":-28.490495,"median":-18.506355,"eighty":-12.102991,"marketCap":4497139206},{"date":"2024-09-13","current":-14.273182,"twenty":-28.490495,"median":-18.365921,"eighty":-12.102991,"marketCap":4404018808},{"date":"2024-09-20","current":-14.672987,"twenty":-28.490495,"median":-18.269068,"eighty":-12.102991,"marketCap":4527379335},{"date":"2024-09-27","current":-13.944938,"twenty":-28.490495,"median":-18.102517,"eighty":-12.102991,"marketCap":4302738376},{"date":"2024-10-04","current":-14.184509,"twenty":-28.490495,"median":-18.102517,"eighty":-12.102991,"marketCap":4376658691},{"date":"2024-10-11","current":-12.924425,"twenty":-28.490495,"median":-18.102517,"eighty":-12.102991,"marketCap":3987857031},{"date":"2024-10-18","current":-14.522087,"twenty":-28.490495,"median":-18.096122,"eighty":-12.102991,"marketCap":4480819136},{"date":"2024-10-25","current":-13.818929,"twenty":-28.490495,"median":-18.063615,"eighty":-12.102991,"marketCap":4263858210},{"date":"2024-10-31","current":-13.916936,"twenty":-28.490495,"median":-18.025749,"eighty":-12.102991,"marketCap":4294098339},{"date":"2024-11-08","current":-14.109838,"twenty":-28.4958,"median":-17.957834,"eighty":-12.097778,"marketCap":4353618593},{"date":"2024-11-15","current":-15.175127,"twenty":-28.4958,"median":-17.957834,"eighty":-12.097778,"marketCap":4718781551},{"date":"2024-11-22","current":-15.302924,"twenty":-28.4958,"median":-17.88108,"eighty":-12.097778,"marketCap":4758520699},{"date":"2024-11-29","current":-15.307599,"twenty":-28.4958,"median":-17.77844,"eighty":-12.097778,"marketCap":4759974570},{"date":"2024-12-06","current":-15.32786,"twenty":-28.449873,"median":-17.629041,"eighty":-12.097778,"marketCap":4766274679},{"date":"2024-12-13","current":-14.707576,"twenty":-28.320039,"median":-17.452847,"eighty":-12.097778,"marketCap":4573394423},{"date":"2024-12-20","current":-13.98599,"twenty":-28.091929,"median":-17.328154,"eighty":-12.097778,"marketCap":4349013622},{"date":"2024-12-27","current":-13.710136,"twenty":-27.950529,"median":-17.237888,"eighty":-12.097778,"marketCap":4263235216},{"date":"2025-01-03","current":-13.608833,"twenty":-27.778537,"median":-17.194427,"eighty":-12.097778,"marketCap":4231734672},{"date":"2025-01-10","current":-12.868545,"twenty":-27.620773,"median":-17.134813,"eighty":-12.092564,"marketCap":4001538386},{"date":"2025-01-17","current":-14.601598,"twenty":-27.401353,"median":-17.062407,"eighty":-12.092564,"marketCap":4540440007},{"date":"2025-01-24","current":-16.19127,"twenty":-27.316594,"median":-17.006543,"eighty":-12.092564,"marketCap":5034756242},{"date":"2025-01-31","current":-16.964286,"twenty":-27.062663,"median":-16.935586,"eighty":-12.092564,"marketCap":5275129627},{"date":"2025-02-07","current":-17.065589,"twenty":-26.869288,"median":-16.889297,"eighty":-12.092564,"marketCap":5306630172},{"date":"2025-02-14","current":-20.522345,"twenty":-26.613063,"median":-16.886581,"eighty":-12.092564,"marketCap":6381525671},{"date":"2025-02-21","current":-21.919439,"twenty":-26.428477,"median":-16.886581,"eighty":-12.092564,"marketCap":6295613527},{"date":"2025-02-28","current":-21.462713,"twenty":-26.259509,"median":-16.886581,"eighty":-12.092564,"marketCap":6164434593},{"date":"2025-03-07","current":-21.12314,"twenty":-25.773705,"median":-16.884764,"eighty":-12.087351,"marketCap":6066903787},{"date":"2025-03-14","current":-20.654529,"twenty":-25.461185,"median":-16.884764,"eighty":-12.087351,"marketCap":5932311274},{"date":"2025-03-21","current":-21.438943,"twenty":-25.440831,"median":-16.884764,"eighty":-12.087351,"marketCap":6157607436},{"date":"2025-03-28","current":-20.674904,"twenty":-25.12508,"median":-16.884764,"eighty":-12.087351,"marketCap":5938163123},{"date":"2025-04-04","current":-18.318267,"twenty":-24.742094,"median":-16.884764,"eighty":-12.087351,"marketCap":5261299329},{"date":"2025-04-11","current":-16.24008,"twenty":-24.602553,"median":-16.762118,"eighty":-12.092564,"marketCap":4664410796},{"date":"2025-04-17","current":-17.737597,"twenty":-24.358761,"median":-16.744642,"eighty":-12.092564,"marketCap":5094521651},{"date":"2025-04-25","current":-17.897196,"twenty":-23.915799,"median":-16.742979,"eighty":-12.087351,"marketCap":5140361130},{"date":"2025-05-02","current":-19.234219,"twenty":-23.617891,"median":-16.742979,"eighty":-12.087351,"marketCap":5524375578},{"date":"2025-05-09","current":-19.261265,"twenty":-23.314094,"median":-16.742979,"eighty":-12.087351,"marketCap":5359870693},{"date":"2025-05-16","current":-19.025033,"twenty":-23.105255,"median":-16.742979,"eighty":-12.087351,"marketCap":5294133855},{"date":"2025-05-23","current":-18.515782,"twenty":-22.831967,"median":-16.742979,"eighty":-12.087351,"marketCap":5152423687},{"date":"2025-05-30","current":-18.567239,"twenty":-22.597152,"median":-16.742979,"eighty":-12.087351,"marketCap":5166742833},{"date":"2025-06-06","current":-19.635423,"twenty":-22.218917,"median":-16.742979,"eighty":-12.087351,"marketCap":5463988550},{"date":"2025-06-13","current":-18.852917,"twenty":-22.04462,"median":-16.742979,"eighty":-12.087351,"marketCap":5246238781},{"date":"2025-06-20","current":-18.256721,"twenty":-21.917988,"median":-16.733475,"eighty":-12.082137,"marketCap":5080334194},{"date":"2025-06-27","current":-18.19994,"twenty":-21.804218,"median":-16.733475,"eighty":-12.082137,"marketCap":5064533758},{"date":"2025-07-03","current":-18.709191,"twenty":-21.676545,"median":-16.733475,"eighty":-12.082137,"marketCap":5206243925},{"date":"2025-07-11","current":-19.647844,"twenty":-21.59765,"median":-16.733475,"eighty":-12.082137,"marketCap":5467444896},{"date":"2025-07-18","current":-19.915777,"twenty":-21.558886,"median":-16.733475,"eighty":-12.082137,"marketCap":5542003207},{"date":"2025-07-25","current":-18.625794,"twenty":-21.532853,"median":-16.733475,"eighty":-12.082137,"marketCap":5183037034},{"date":"2025-08-01","current":-17.988788,"twenty":-21.483271,"median":-16.733475,"eighty":-12.082137,"marketCap":5005775883},{"date":"2025-08-08","current":-21.084338,"twenty":-21.429036,"median":-16.733475,"eighty":-12.082137,"marketCap":5205723123},{"date":"2025-08-15","current":-21.979695,"twenty":-21.389816,"median":-16.733475,"eighty":-12.082137,"marketCap":5426786711},{"date":"2025-08-22","current":-23.675416,"twenty":-21.389816,"median":-16.733475,"eighty":-12.082137,"marketCap":5845460187},{"date":"2025-08-29","current":-24.607153,"twenty":-21.389816,"median":-16.733475,"eighty":-12.082137,"marketCap":6075506042},{"date":"2025-09-05","current":-25.144771,"twenty":-21.376122,"median":-16.723971,"eighty":-12.076924,"marketCap":6208243997},{"date":"2025-09-12","current":-24.851709,"twenty":-21.389816,"median":-16.733475,"eighty":-12.082137,"marketCap":6135886841},{"date":"2025-09-19","current":-23.976563,"twenty":-21.389816,"median":-16.733475,"eighty":-12.082137,"marketCap":5919813402},{"date":"2025-09-26","current":-23.447029,"twenty":-21.389816,"median":-16.733475,"eighty":-12.082137,"marketCap":5789071506},{"date":"2025-10-03","current":-24.24133,"twenty":-21.389816,"median":-16.733475,"eighty":-12.082137,"marketCap":5985184350},{"date":"2025-10-10","current":-24.762779,"twenty":-21.389816,"median":-16.733475,"eighty":-12.082137,"marketCap":6113930187},{"date":"2025-10-17","current":-25.264017,"twenty":-21.389816,"median":-16.733475,"eighty":-12.082137,"marketCap":6237685875},{"date":"2025-10-24","current":-25.680368,"twenty":-21.389816,"median":-16.733475,"eighty":-12.082137,"marketCap":6340482938},{"date":"2025-10-31","current":-26.911231,"twenty":-21.389816,"median":-16.733475,"eighty":-12.082137,"marketCap":6644382994},{"date":"2025-11-07","current":-30.619605,"twenty":-21.389816,"median":-16.733475,"eighty":-12.082137,"marketCap":7028026142},{"date":"2025-11-14","current":-30.178135,"twenty":-21.389816,"median":-16.733475,"eighty":-12.082137,"marketCap":6926696736},{"date":"2025-11-21","current":-31.47619,"twenty":-21.389816,"median":-16.733475,"eighty":-12.082137,"marketCap":7224635438},{"date":"2025-11-28","current":-33.275018,"twenty":-21.389816,"median":-16.733475,"eighty":-12.082137,"marketCap":7637514960},{"date":"2025-12-05","current":-32.515073,"twenty":-21.389816,"median":-16.733475,"eighty":-12.082137,"marketCap":7463087225},{"date":"2025-12-12","current":-32.671016,"twenty":-21.389816,"median":-16.733475,"eighty":-12.082137,"marketCap":7498880200},{"date":"2025-12-19","current":-32.286651,"twenty":-21.389816,"median":-16.733475,"eighty":-12.082137,"marketCap":7410658080},{"date":"2025-12-26","current":-33.745041,"twenty":-21.389816,"median":-16.733475,"eighty":-12.082137,"marketCap":7745398009},{"date":"2026-01-02","current":-40.114516,"twenty":-21.389816,"median":-16.733475,"eighty":-12.082137,"marketCap":9207364569},{"date":"2026-01-09","current":-36.800193,"twenty":-21.389816,"median":-16.733475,"eighty":-12.082137,"marketCap":8446637832},{"date":"2026-01-16","current":-38.247601,"twenty":-21.389816,"median":-16.733475,"eighty":-12.082137,"marketCap":8778857129},{"date":"2026-01-23","current":-41.067741,"twenty":-21.389816,"median":-16.733475,"eighty":-12.082137,"marketCap":9426155427},{"date":"2026-01-30","current":-40.691064,"twenty":-21.389816,"median":-16.733475,"eighty":-12.082137,"marketCap":9339697749},{"date":"2026-02-06","current":-39.719169,"twenty":-21.389816,"median":-16.733475,"eighty":-12.082137,"marketCap":9116621817},{"date":"2026-02-13","current":-40.180407,"twenty":-21.389816,"median":-16.733475,"eighty":-12.082137,"marketCap":9222488361},{"date":"2026-02-20","current":-40.890933,"twenty":-21.389816,"median":-16.733475,"eighty":-12.082137,"marketCap":9385573252},{"date":"2026-02-27","current":-45.572544,"twenty":-21.389816,"median":-16.733475,"eighty":-12.082137,"marketCap":8347705231},{"date":"2026-03-06","current":-45.089423,"twenty":-21.389816,"median":-16.733475,"eighty":-12.082137,"marketCap":8259210041},{"date":"2026-03-13","current":-43.03965,"twenty":-21.389816,"median":-16.733475,"eighty":-12.082137,"marketCap":7883744900},{"date":"2026-03-20","current":-44.368931,"twenty":-21.389816,"median":-16.733475,"eighty":-12.082137,"marketCap":8127234556},{"date":"2026-03-27","current":-45.87275,"twenty":-21.397007,"median":-16.733475,"eighty":-12.082137,"marketCap":8402695017}],"updateTime":1774694999856},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"AXSM\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2622761110","title":"Axsome Therapeutics Is Maintained at Buy by Guggenheim","url":"https://stock-news.laohu8.com/highlight/detail?id=2622761110","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622761110?lang=en_us&edition=fundamental","pubTime":"2026-03-25 20:54","pubTimestamp":1774443240,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/AXSM/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 25, 2026 08:54 ET (12:54 GMT)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":"8603dabb40994e59ac78c04c930c0d49","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AXSM"],"gpt_icon":0},{"id":"2622750027","title":"Axsome Therapeutics price target raised to $245 from $220 at Guggenheim","url":"https://stock-news.laohu8.com/highlight/detail?id=2622750027","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622750027?lang=en_us&edition=fundamental","pubTime":"2026-03-25 18:51","pubTimestamp":1774435883,"startTime":"0","endTime":"0","summary":"Guggenheim raised the firm’s price target on Axsome Therapeutics (AXSM) to $245 from $220 and keeps a Buy rating on the shares. The firm increased ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/axsome-therapeutics-price-target-raised-to-245-from-220-at-guggenheim-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/axsome-therapeutics-price-target-raised-to-245-from-220-at-guggenheim-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AXSM"],"gpt_icon":0},{"id":"2619111562","title":"Axsome Still Offers 'Compelling' Core Story, RBC Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2619111562","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619111562?lang=en_us&edition=fundamental","pubTime":"2026-03-14 00:36","pubTimestamp":1773419791,"startTime":"0","endTime":"0","summary":"Axsome Therapeutics  is presenting a buying opportunity following a recent pullback in its shares amid no meaningful fundamental changes, RBC Capital Markets said in a note Friday.The report said the Street was undervaluing the revenue opportunity in agitation disorder heading into the April 30 date for the US Food and Drug Administration to make a decision on its drug candidate AXS-05.\"We still see an 85% chance of approval, and think upside on an approval could be as much as 30%,\" the report said.The note pointed to some $1.6 billion potential out-year opportunity in ADA and a growing business in major depressive disorder, in addition to other assets and catalysts.\"The core story remains compelling,\" the report said. RBC kept its outperform rating and a $222 price target.Price: 155.46, Change: +1.34, Percent Change: +0.87","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4007","AXSM","BK4505","BK4585"],"gpt_icon":0},{"id":"2619192382","title":"RBC Capital Remains a Buy on Axsome Therapeutics (AXSM)","url":"https://stock-news.laohu8.com/highlight/detail?id=2619192382","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619192382?lang=en_us&edition=fundamental","pubTime":"2026-03-13 20:15","pubTimestamp":1773404153,"startTime":"0","endTime":"0","summary":"RBC Capital analyst Leonid Timashev maintained a Buy rating on Axsome Therapeutics today and set a price target of $222.00. According to TipRanks, ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/rbc-capital-remains-a-buy-on-axsome-therapeutics-axsm-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/rbc-capital-remains-a-buy-on-axsome-therapeutics-axsm-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0310800379.SGD","BK4585","BK4505","LU0029864427.USD","BK4007","LU0708994859.HKD","AXSM","LU0128525929.USD","LU1267930573.SGD","BK4207"],"gpt_icon":0},{"id":"2618361959","title":"Should Axsome’s New Solriamfetol Phase 3 and AXS-05 Priority Review Prompt Action From AXSM Investors?","url":"https://stock-news.laohu8.com/highlight/detail?id=2618361959","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618361959?lang=en_us&edition=fundamental","pubTime":"2026-03-10 21:15","pubTimestamp":1773148550,"startTime":"0","endTime":"0","summary":"Axsome Therapeutics recently dosed the first patient in its CLARITY Phase 3 trial of solriamfetol for major depressive disorder with excessive daytime sleepiness and has also been granted FDA Priority Review for AXS-05 in Alzheimer’s disease agitation, while management engaged investors at several March healthcare conferences.\nTogether, the new late-stage solriamfetol study and the upcoming AXS-05 regulatory decision highlight how Axsome is steadily broadening its central nervous system...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-axsm/axsome-therapeutics/news/should-axsomes-new-solriamfetol-phase-3-and-axs-05-priority","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-axsm/axsome-therapeutics/news/should-axsomes-new-solriamfetol-phase-3-and-axs-05-priority","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0154245673.USD","ISBC","AXSM","AXS","LU0154245756.USD","LU0963586101.USD","BK4107","BK4211","BK4007","BK4585","BK4505"],"gpt_icon":0},{"id":"2616346292","title":"Should Axsome’s Revenue Jump and SUNOSI IP Win Require Action From Axsome Therapeutics (AXSM) Investors?","url":"https://stock-news.laohu8.com/highlight/detail?id=2616346292","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616346292?lang=en_us&edition=fundamental","pubTime":"2026-03-03 18:21","pubTimestamp":1772533268,"startTime":"0","endTime":"0","summary":"In late February 2026, Axsome Therapeutics reported fourth-quarter 2025 revenue of US$196 million and full-year revenue of US$638.5 million, with net losses narrowing year over year, while also settling SUNOSI patent litigation with Alkem and dosing the first patient in its Phase 3 CLARITY trial of solriamfetol in major depressive disorder with excessive daytime sleepiness.\nTaken together with upcoming healthcare conference presentations, these updates underscore Axsome’s efforts to both...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-axsm/axsome-therapeutics/news/should-axsomes-revenue-jump-and-sunosi-ip-win-require-action","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-axsm/axsome-therapeutics/news/should-axsomes-revenue-jump-and-sunosi-ip-win-require-action","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["IP","ISBC","AXSM"],"gpt_icon":0},{"id":"2614893001","title":"Axsome Therapeutics Director Mark Coleman Disposes of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2614893001","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614893001?lang=en_us&edition=fundamental","pubTime":"2026-02-28 08:00","pubTimestamp":1772236854,"startTime":"0","endTime":"0","summary":"Mark Coleman, a director of Axsome Therapeutics Inc., reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Axsome Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on February 27, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260228:nNDL7mGrxy:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Axsome Therapeutics Director Mark Coleman Disposes of Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","AXSM","BK4007","BK4505"],"gpt_icon":0},{"id":"2614362138","title":"Axsome Explores Solriamfetol In Phase 3 CLARITY Trial For MDD Subset","url":"https://stock-news.laohu8.com/highlight/detail?id=2614362138","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614362138?lang=en_us&edition=fundamental","pubTime":"2026-02-27 17:41","pubTimestamp":1772185272,"startTime":"0","endTime":"0","summary":"Axsome Therapeutics (NasdaqGM: AXSM) has started the CLARITY Phase 3 trial of solriamfetol in major depressive disorder with excessive daytime sleepiness.\nThe trial focuses on a group of MDD patients who experience excessive daytime sleepiness, for which no approved treatments are currently available.\nThis study expands Axsome's clinical program into an area of unmet medical need.\n\nAxsome Therapeutics, listed on the NasdaqGM under the ticker AXSM, develops therapies for central nervous...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-axsm/axsome-therapeutics/news/axsome-explores-solriamfetol-in-phase-3-clarity-trial-for-md","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-axsm/axsome-therapeutics/news/axsome-explores-solriamfetol-in-phase-3-clarity-trial-for-md","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["ABVC","AXSM","BK4505","BK4585","BK4139","BK4007"],"gpt_icon":0},{"id":"2614084479","title":"Axsome Therapeutics to Participate in Upcoming Investor Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2614084479","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614084479?lang=en_us&edition=fundamental","pubTime":"2026-02-25 20:00","pubTimestamp":1772020800,"startTime":"0","endTime":"0","summary":"NEW YORK, Feb.  25, 2026  (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/02/25/3244451/33090/en/Axsome-Therapeutics-to-Participate-in-Upcoming-Investor-Conferences.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4505","BK4007","BK4135","AXSM","BK4585","CNS"],"gpt_icon":0},{"id":"2613371901","title":"RBC Raises Price Target on Axsome Therapeutics to $222 From $219, Keeps Outperform Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2613371901","media":"MT Newswires Live","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613371901?lang=en_us&edition=fundamental","pubTime":"2026-02-24 20:51","pubTimestamp":1771937473,"startTime":"0","endTime":"0","summary":"Axsome Therapeutics (AXSM) has an average rating of buy and mean price target of $223.65, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from majo","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["AXSM"],"gpt_icon":0},{"id":"2613771943","title":"Axsome Therapeutics Initiated at Outperform by Wolfe Research","url":"https://stock-news.laohu8.com/highlight/detail?id=2613771943","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613771943?lang=en_us&edition=fundamental","pubTime":"2026-02-24 20:41","pubTimestamp":1771936860,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/AXSM/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  February 24, 2026 07:41 ET (12:41 GMT)","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AXSM"],"gpt_icon":0},{"id":"2613671995","title":"Axsome announces first patient dosed in CLARITY Phase 3 trial of solriamfetol","url":"https://stock-news.laohu8.com/highlight/detail?id=2613671995","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613671995?lang=en_us&edition=fundamental","pubTime":"2026-02-24 20:39","pubTimestamp":1771936754,"startTime":"0","endTime":"0","summary":"Axsome Therapeutics (AXSM) announced that the first patient has been dosed in the CLARITY Phase 3 trial of solriamfetol in the treatment of major d...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/axsome-announces-first-patient-dosed-in-clarity-phase-3-trial-of-solriamfetol-thefly-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/axsome-announces-first-patient-dosed-in-clarity-phase-3-trial-of-solriamfetol-thefly-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4505","AXSM","BK4007"],"gpt_icon":0},{"id":"2613150927","title":"BRIEF-Axsome Therapeutics Initiates Clarity Phase 3 Trial Of Solriamfetol In Adults With Major Depressive Disorder","url":"https://stock-news.laohu8.com/highlight/detail?id=2613150927","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613150927?lang=en_us&edition=fundamental","pubTime":"2026-02-24 20:09","pubTimestamp":1771934959,"startTime":"0","endTime":"0","summary":"BRIEF-Axsome Therapeutics Initiates Clarity Phase 3 Trial Of Solriamfetol In Adults With Major Depressive DisorderFeb 24 (Reuters) - Axsome Therapeutics Inc AXSM.O:AXSOME THERAPEUTICS INITIATES CLARIT","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260224:nTUA9NDBT8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","AXSM","BK4505","BK4007"],"gpt_icon":0},{"id":"2613715206","title":"Axsome doses first patient in CLARITY Phase 3 solriamfetol trial for MDD with excessive daytime sleepiness symptoms","url":"https://stock-news.laohu8.com/highlight/detail?id=2613715206","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613715206?lang=en_us&edition=fundamental","pubTime":"2026-02-24 20:04","pubTimestamp":1771934653,"startTime":"0","endTime":"0","summary":"Axsome Therapeutics, Inc. announced that the first patient has been dosed in the CLARITY Phase 3 trial evaluating solriamfetol for major depressive disorder with excessive daytime sleepiness symptoms. CLARITY is a double-blind, placebo-controlled, multicenter randomized withdrawal study with an open-label treatment period followed by a randomized phase in which responders continue solriamfetol or switch to placebo; the primary endpoint is time from randomization to relapse of depressive symptoms. No trial results were presented in the announcement; results are expected to be reported in the future.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Axsome Therapeutics Inc. published the original content used to generate this news brief on ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260224:nNDLbnrnl4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AXSM","BK4007","BK4505","BK4585"],"gpt_icon":0},{"id":"2613071558","title":"Axsome Therapeutics Initiates Clarity Phase 3 Trial of Solriamfetol in Adults With Major Depressive Disorder With Excessive Daytime Sleepiness Symptoms","url":"https://stock-news.laohu8.com/highlight/detail?id=2613071558","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613071558?lang=en_us&edition=fundamental","pubTime":"2026-02-24 20:00","pubTimestamp":1771934409,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260224:nTUA9NDBT8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","AXSM","BK4585","BK4505"],"gpt_icon":0},{"id":"2613678713","title":"RBC Capital Sticks to Their Buy Rating for Axsome Therapeutics (AXSM)","url":"https://stock-news.laohu8.com/highlight/detail?id=2613678713","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613678713?lang=en_us&edition=fundamental","pubTime":"2026-02-24 19:37","pubTimestamp":1771933053,"startTime":"0","endTime":"0","summary":"RBC Capital analyst Leonid Timashev maintained a Buy rating on Axsome Therapeutics yesterday and set a price target of $222.00. The company’s share...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/rbc-capital-sticks-to-their-buy-rating-for-axsome-therapeutics-axsm-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/rbc-capital-sticks-to-their-buy-rating-for-axsome-therapeutics-axsm-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AXSM"],"gpt_icon":0},{"id":"2613718957","title":"Axsome Therapeutics price target raised to $202 from $193 at Wells Fargo","url":"https://stock-news.laohu8.com/highlight/detail?id=2613718957","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613718957?lang=en_us&edition=fundamental","pubTime":"2026-02-24 19:16","pubTimestamp":1771931803,"startTime":"0","endTime":"0","summary":"Wells Fargo raised the firm’s price target on Axsome Therapeutics (AXSM) to $202 from $193 and keeps an Overweight rating on the shares. The firm c...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/axsome-therapeutics-price-target-raised-to-202-from-193-at-wells-fargo-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/axsome-therapeutics-price-target-raised-to-202-from-193-at-wells-fargo-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AXSM"],"gpt_icon":0},{"id":"2613379890","title":"U.S. RESEARCH ROUNDUP-Dollar General, Keysight Technologies, Teledyne Technologies","url":"https://stock-news.laohu8.com/highlight/detail?id=2613379890","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613379890?lang=en_us&edition=fundamental","pubTime":"2026-02-24 15:56","pubTimestamp":1771919787,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-Dollar General, Keysight Technologies, Teledyne TechnologiesFeb 24 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed comp","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260224:nL4N3ZK0LQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TPG","DIPS","UCTT","EHAB","APO","CG","EVER","BX","KEYS","AVS","TDY","OKTG","JLL","FRPT","AVGW","NTSK","AVL","2NVD.UK","AVGU","GH","ZS","BBBY","AVGX","3NVD.UK","AXSM","SMG","AVGO","VVX","HRMY","WDAY","WHD","CRWL","DG","OKTA","SAIL","MRVL","KKR","WGS","AVGG","CRWD","LH","MNST","DPZ","NVD2.UK","NVDA","NVIW.SI","LIFE","ARES","MAX","SMTC"],"gpt_icon":1},{"id":"2613751518","title":"Axsome Therapeutics Signals Strong Growth in Earnings Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2613751518","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613751518?lang=en_us&edition=fundamental","pubTime":"2026-02-24 08:28","pubTimestamp":1771892883,"startTime":"0","endTime":"0","summary":"Axsome Therapeutics Inc. (($AXSM)) has held its Q4 earnings call. Read on for the main highlights of the call. Axsome Therapeutics’ latest earnings...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/axsome-therapeutics-signals-strong-growth-in-earnings-call?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/axsome-therapeutics-signals-strong-growth-in-earnings-call?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AXSM"],"gpt_icon":0},{"id":"2613739172","title":"Axsome Therapeutics price target raised to $215 from $195 at TD Cowen","url":"https://stock-news.laohu8.com/highlight/detail?id=2613739172","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613739172?lang=en_us&edition=fundamental","pubTime":"2026-02-24 01:45","pubTimestamp":1771868716,"startTime":"0","endTime":"0","summary":"TD Cowen analyst Joseph Thome raised the firm’s price target on Axsome Therapeutics (AXSM) to $215 from $195 and keeps a Buy rating on the shares. ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/axsome-therapeutics-price-target-raised-to-215-from-195-at-td-cowen-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/axsome-therapeutics-price-target-raised-to-215-from-195-at-td-cowen-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["COWN","AXSM","TD"],"gpt_icon":0}],"pageSize":20,"totalPage":8,"pageCount":1,"totalSize":156,"code":"91000000","status":"200"}]}}